Can exhaled nitric oxide fraction predict adherence to inhaled corticosteroids in atopic and nonatopic children with asthma?-Reference-Cited by-同舟云学术

Can exhaled nitric oxide fraction predict adherence to inhaled corticosteroids in atopic and nonatopic children with asthma?

Published:2017-03 Issue:2 Volume:5 Page:521-522
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Klok Ted,Brand Paul L.P.

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference10 articles.

1. Exhaled nitric oxide and the management of childhood asthma—yet another promising biomarker “has been” or a misunderstood gem;Turner;Paediatr Respir Rev,2015

2. FeNO and asthma treatment in children: a systematic review and meta-analysis;Lu;Medicine (Baltimore),2015

3. Changes of exhaled nitric oxide during steroid treatment of childhood asthma;Beck-Ripp;Eur Respir J,2002

4. Long-term adherence to inhaled corticosteroids in children with asthma: observational study;Klok;Respir Med,2015

5. High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs;Klok;Eur Respir J,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interval change in fractional exhaled nitric oxide (FENO) reflects short-term change in adherence following electronic inhaler reminders;Journal of Asthma;2023-02-06

2. Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases;Therapeutic Advances in Chronic Disease;2023-01

3. Application of exhaled nitric oxide (FeNO) in pediatric asthma;Current Opinion in Allergy & Clinical Immunology;2021-01-18

4. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review;Clinical & Experimental Allergy;2020-11-27

5. Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST);The Journal of Allergy and Clinical Immunology: In Practice;2020-11